GS0011: Nucleic acids, biotechnology formed genes, enzymes, and protein arrays for industrial, agricultural, and scientific research use in the fields of biotechnology, nanotechnology and proteomics; Pharmaceutical preparations for scientific laboratory research in the fields of biotechnology, nanotechnology and proteomics, namely, pharmaceutical preparations for use in the collection of tissue samples and fluid samples, pharmaceutical preparations for use in growth hormone screening, cancer screening, anti-doping screening, biomedical screening, and pharmaceutical preparations for use in protein analysis, and biomedical analysis
GS0051: pharmaceutical preparations for diagnosis and treatment of cancer, infectious diseases, genetic inherited disease, and blood disorders, in persons and animals
GS0091: Measuring apparatus for measuring proteins, DNA, RNA, and isoforms of the same, namely, nano-particles for use as measuring apparatus for scientific research in laboratories; Medical measuring apparatus for measuring proteins, DNA, RNA, and isoforms of the same, namely, nano-particles for use as medical measuring apparatus for medical research in laboratories and medical analysis services using nano-particles and bio-marker analysis for collection of tissue samples and fluid samples, growth hormone screening, cancer screening, anti-doping screening, biomedical screening, protein analysis, and biomedical analysis
GS0101: Medical measuring apparatus for measuring proteins, DNA, RNA, and isoforms of the same, namely, nano-particles for use as medical measuring apparatus for diagnosis and treatment of cancer, infectious diseases, genetic inherited diseases, and blood disorders in persons and animals
GS0421: Scientific and technological research services in the field of biotechnology, nanotechnology and proteomics, as it relates to collection of tissue samples and fluid samples, growth hormone screening, cancer screening, anti-doping screening, biomedical screening, protein analysis, and biomedical analysis, and diagnosis and treatment of cancer, infectious diseases, genetic inherited disease, and blood disorders, in persons, animals, and materials; scientific and technological research services in the field of biotechnology, nanotechnology and proteomics using fluids, earths, and other materials or substances, namely, nucleic acids, genes, enzymes, and proteins, for scientific, pharmaceutical, industrial, agricultural, medical and scientific research use
GS0441: Medical diagnostic testing in the field of nanotechnology, biotechnology and proteomics, namely, using biomarker analysis for collection of tissue samples and fluid samples, growth hormone screening, cancer screening, anti-doping screening, biomedical screening, protein analysis, and biomedical analysis, and diagnosis and treatment of cancer, infectious diseases, genetic inherited disease, and blood disorders, in persons, animals, and materials
Case File Event Statements
12/16/2016 - 7 years ago
46 - CANCELLED SEC. 8 (6-YR)Type:C8..
5/11/2010 - 14 years ago
45 - REGISTERED-PRINCIPAL REGISTERType:R.PR
2/23/2010 - 14 years ago
44 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
2/23/2010 - 14 years ago
43 - PUBLISHED FOR OPPOSITIONType:PUBO
1/15/2010 - 14 years ago
42 - LAW OFFICE PUBLICATION REVIEW COMPLETEDType:PREV
1/12/2010 - 14 years ago
41 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
1/12/2010 - 14 years ago
40 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
1/12/2010 - 14 years ago
39 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
1/12/2010 - 14 years ago
38 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
1/12/2010 - 14 years ago
37 - EXAMINERS AMENDMENT -WRITTENType:CNEA
1/6/2010 - 14 years ago
36 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
1/6/2010 - 14 years ago
35 - NON-FINAL ACTION E-MAILEDType:GNRT
1/6/2010 - 14 years ago
34 - NON-FINAL ACTION WRITTENType:CNRT
12/7/2009 - 14 years ago
33 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
12/7/2009 - 14 years ago
32 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
12/5/2009 - 14 years ago
31 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
11/5/2009 - 14 years ago
30 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
11/5/2009 - 14 years ago
29 - NON-FINAL ACTION E-MAILEDType:GNRT
11/5/2009 - 14 years ago
28 - NON-FINAL ACTION WRITTENType:CNRT
11/5/2009 - 14 years ago
27 - PREVIOUS ALLOWANCE COUNT WITHDRAWNType:ZZZX
10/9/2009 - 14 years ago
26 - WITHDRAWN FROM PUB - OG REVIEW QUERYType:PBCR
9/28/2009 - 14 years ago
25 - LAW OFFICE PUBLICATION REVIEW COMPLETEDType:PREV
9/28/2009 - 14 years ago
24 - ASSIGNED TO LIEType:ALIE
9/17/2009 - 14 years ago
23 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
9/17/2009 - 14 years ago
22 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
9/17/2009 - 14 years ago
21 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
9/17/2009 - 14 years ago
20 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
9/17/2009 - 14 years ago
19 - EXAMINERS AMENDMENT -WRITTENType:CNEA
9/4/2009 - 14 years ago
18 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
9/4/2009 - 14 years ago
17 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
9/4/2009 - 14 years ago
16 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
5/15/2009 - 15 years ago
15 - ASSIGNED TO EXAMINERType:DOCK
4/23/2009 - 15 years ago
14 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
4/23/2009 - 15 years ago
13 - NON-FINAL ACTION E-MAILEDType:GNRT
4/23/2009 - 15 years ago
12 - NON-FINAL ACTION WRITTENType:CNRT
4/23/2009 - 15 years ago
11 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
4/23/2009 - 15 years ago
10 - NON-FINAL ACTION E-MAILEDType:GNRT
4/23/2009 - 15 years ago
9 - NON-FINAL ACTION WRITTENType:CNRT
4/7/2009 - 15 years ago
8 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
4/6/2009 - 15 years ago
7 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
4/6/2009 - 15 years ago
6 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
10/9/2008 - 15 years ago
5 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN